In the News
2021
April 15, 2021
CRISPR treating cancer, Rachel Haurwitz, Co-founder and CEO, Caribou Biosciences
February 23, 2021
Caribou and AbbVie Initiate Development Partnership for CAR T-Cell Products
February 18, 2021
AbbVie and Caribou Team Up On Next-Gen Off-the-Shelf CAR-T Therapies
February 10, 2021
AbbVie, Caribou Biosciences Collaborate in $40 Million CAR-T Cell Deal
2020
March 8, 2020
CRISPR Technology: Where Female Entrepreneurs Thrive
2019
November 19, 2019
Harnessing Type I CRISPR-Cas Systems for Genome Engineering in Human Cells
May 14, 2019
Gene Hackers: The Young Biotech Entrepreneurs Looking to make Billions by Editing Life Itself
2018
March 16, 2018
This Scientist Turned CEO Wants to Gene-Edit a Way to Cure Cancer
2017
November 30, 2017
Diverse Perspectives — Insights for 2018 From Biopharma's Leading Women
October 9, 2017
Meet the 30 biotech leaders under 40 who are searching for breakthrough treatments and shaping the future of medicine
September 11, 2017
In the CRISPR pipeline – Rachel Haurwitz, CEO Caribou Biosciences
August 16, 2017
MIT Technology Review: 35 Innovators Under 35
May 16, 2017
Caribou Bioscience’s CEO on CRISPR’s legal and ethical challenges
May 15, 2017
Nature Biotechnology First Rounders Podcast
May 2, 2017
Researchers Publish Two New Methods for Analysis of CRISPR Off-Target Effects
April 14, 2017
From corn to cattle, gene editing is about to supercharge agriculture
